PA03.07. A clinical comparative study of Matra Vasti and Vaitran Vasti in the treatment of Gridhrasi w.s.r to Sciatica

PURPOSE: Sciatica is a vata dominant vikar and vasti is a vata dominant chikitsa. Matra Vasti is a nirapad vasti and can be given in any condition without following the ahara and vihara, then what is need for Vaitran Vasti? So, here an effort was made to study the effect of Matra vasti and Vaitran Vasti separately in the treatment of Grihdrasi. METHOD: 30 patients were randomly selected from the OPD and IPD of Kayachikitsa Department of Ayurvedic Medical College,Davanagere, Karnataka and were separated in two groups of 15 each,and a study was conducted. Along with vasti chikitsa oral medication was also given. Ekangvir rasa in the dose of 500mg B.D and Lashunadi vati in the dose of 2 tabs. B.D. RESULT: Results were evaluated on the basis of symptoms of types of Gridhrasi i.e vataja and vatakaphaja as mentioned in Charak Samhita which showed marked improvement in all the symptoms. A Ttest was performed which gave a significant result of (P<.001). Results were also seen on the basis of International Scale which resulted in improvement in functional ability and reduction in functional disability. CONCLUSION: It can be said that Vasti plays an important role in the treatment of Grihdrasi. In Vataja type Matra Vasti had played an supreme role as it helps in treating degenerative pathology and in Vatakaphaja type Vaitran Vasti had played a first rate role as it helps in treating inflammatory pathology.